Sep 23,2021 02:50 PM
DR Reddys was under pressure to emerge as the biggest laggard.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||820.00||87.67||184,676.81||419.30||0.97||3,312.54||104.36|
|Divis Laboratories Ltd||5,247.25||67.24||135,436.76||551.97||0.39||1,950.16||349.25|
|Dr Reddys Laboratories Ltd||5,260.00||48.34||79,751.72||413.40||0.52||3,410.10||1,032.48|
|Piramal Enterprises Ltd||2,810.05||210.19||66,165.93||53.13||1.12||512.78||989.09|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. With a portfolio of more than 800 b... More
Reports by alkem-laboratories-ltd-share-price
Sep 26, 2021 11:30 AM
The company’s consolidated revenue in the period stood at Rs1,918.92cr, up 3.22% yoy and 15.66% qoq.
27 Aug 2021
25 May 2021
AGM 27.08.2021This is with reference to our earlier intimation letter dated today for outcome of the... More
25 May 2021
09 Aug 2021
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting he... More
06 Aug 2021
26 Jul 2021
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is ... More